Napa, CA, United States of America

Michael Delmage


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Delmage

Introduction

Michael Delmage is a notable inventor based in Napa, California, recognized for his significant contributions to the field of medical technology. He holds a patent for a modular hemofiltration apparatus that enhances patient therapy through an interactive control system. His work exemplifies the intersection of innovation and healthcare, aiming to improve patient outcomes.

Latest Patents

Delmage's most recent patent is titled "Modular Hemofiltration Apparatus with Interactive Operator Instructions and Control System." This apparatus is designed for fluid management and renal replacement therapy. It features an interactive operator control system that allows for the selective changing of panel kits, filter cartridges, and patient therapies during ongoing treatments. The system also provides operator instructions and identifies setup steps, ensuring a streamlined process for healthcare providers.

Career Highlights

Throughout his career, Michael Delmage has demonstrated a commitment to advancing medical technology. His work at B. Braun Avitum AG has positioned him as a key player in the development of innovative healthcare solutions. His patent reflects his dedication to improving patient care through technology.

Collaborations

Delmage has collaborated with notable colleagues, including Harold W. Peters and Adam Heintzelman. These partnerships have contributed to the successful development and implementation of his innovative ideas.

Conclusion

Michael Delmage's contributions to medical technology through his patent for a modular hemofiltration apparatus highlight the importance of innovation in healthcare. His work continues to influence the field, showcasing the potential for technology to enhance patient therapy and outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…